287 related articles for article (PubMed ID: 7479982)
21. Tumor necrosis factor blockade in actively induced experimental autoimmune encephalomyelitis prevents clinical disease despite activated T cell infiltration to the central nervous system.
Körner H; Lemckert FA; Chaudhri G; Etteldorf S; Sedgwick JD
Eur J Immunol; 1997 Aug; 27(8):1973-81. PubMed ID: 9295034
[TBL] [Abstract][Full Text] [Related]
22. Anti-inflammatory Therapy With Simvastatin Improves Neuroinflammation and CNS Function in a Mouse Model of Metachromatic Leukodystrophy.
Stein A; Stroobants S; Gieselmann V; D'Hooge R; Matzner U
Mol Ther; 2015 Jul; 23(7):1160-1168. PubMed ID: 25896249
[TBL] [Abstract][Full Text] [Related]
23. ADAM-10 and ADAM-17 in the inflamed human CNS.
Kieseier BC; Pischel H; Neuen-Jacob E; Tourtellotte WW; Hartung HP
Glia; 2003 Jun; 42(4):398-405. PubMed ID: 12730960
[TBL] [Abstract][Full Text] [Related]
24. Involvement of neuropsin in the pathogenesis of experimental autoimmune encephalomyelitis.
Terayama R; Bando Y; Yamada M; Yoshida S
Glia; 2005 Nov; 52(2):108-18. PubMed ID: 15920728
[TBL] [Abstract][Full Text] [Related]
25. Tumor necrosis factor-alpha regulation of insulin-like growth factor-I, type 1 IGF receptor, and IGF binding protein expression in cerebellum of transgenic mice.
Ye P; Price W; Kassiotis G; Kollias G; D'Ercole AJ
J Neurosci Res; 2003 Mar; 71(5):721-31. PubMed ID: 12584730
[TBL] [Abstract][Full Text] [Related]
26. Expression of the human histocompatibility leukocyte antigen DR3 transgene reduces the severity of demyelination in a murine model of multiple sclerosis.
Drescher KM; Nguyen LT; Taneja V; Coenen MJ; Leibowitz JL; Strauss G; Hammerling GJ; David CS; Rodriguez M
J Clin Invest; 1998 Apr; 101(8):1765-74. PubMed ID: 9541508
[TBL] [Abstract][Full Text] [Related]
27. Insulin-like growth factor-I ameliorates demyelination induced by tumor necrosis factor-alpha in transgenic mice.
Ye P; Kollias G; D'Ercole AJ
J Neurosci Res; 2007 Mar; 85(4):712-22. PubMed ID: 17279553
[TBL] [Abstract][Full Text] [Related]
28. The TIM-3 pathway ameliorates Theiler's murine encephalomyelitis virus-induced demyelinating disease.
Kaneyama T; Tomiki H; Tsugane S; Inaba Y; Ichikawa M; Akiba H; Yagita H; Kim BS; Koh CS
Int Immunol; 2014 Jul; 26(7):369-81. PubMed ID: 24486565
[TBL] [Abstract][Full Text] [Related]
29. Transgenic models to assess the pathogenic actions of cytokines in the central nervous system.
Campbell IL; Stalder AK; Chiang CS; Bellinger R; Heyser CJ; Steffensen S; Masliah E; Powell HC; Gold LH; Henriksen SJ; Siggins GR
Mol Psychiatry; 1997 Mar; 2(2):125-9. PubMed ID: 9106234
[TBL] [Abstract][Full Text] [Related]
30. Tumefactive demyelinating lesions during etanercept treatment requiring decompressive hemicraniectomy.
Cereda CW; Zecca C; Mazzucchelli L; Valci L; Staedler C; Bassetti CL; Gobbi C
Mult Scler; 2013 May; 19(6):820-3. PubMed ID: 23069873
[TBL] [Abstract][Full Text] [Related]
31. Astrocyte-specific but not neuron-specific transmembrane TNF triggers inflammation and degeneration in the central nervous system of transgenic mice.
Akassoglou K; Probert L; Kontogeorgos G; Kollias G
J Immunol; 1997 Jan; 158(1):438-45. PubMed ID: 8977220
[TBL] [Abstract][Full Text] [Related]
32. Platelet-derived growth factor regulates oligodendrocyte progenitor numbers in adult CNS and their response following CNS demyelination.
Woodruff RH; Fruttiger M; Richardson WD; Franklin RJ
Mol Cell Neurosci; 2004 Feb; 25(2):252-62. PubMed ID: 15019942
[TBL] [Abstract][Full Text] [Related]
33. Autoantigen specific T cells inhibit glutamate uptake in astrocytes by decreasing expression of astrocytic glutamate transporter GLAST: a mechanism mediated by tumor necrosis factor-alpha.
Korn T; Magnus T; Jung S
FASEB J; 2005 Nov; 19(13):1878-80. PubMed ID: 16123171
[TBL] [Abstract][Full Text] [Related]
34. Estrogen inhibits systemic T cell expression of TNF-alpha and recruitment of TNF-alpha(+) T cells and macrophages into the CNS of mice developing experimental encephalomyelitis.
Ito A; Buenafe AC; Matejuk A; Zamora A; Silverman M; Dwyer J; Vandenbark AA; Offner H
Clin Immunol; 2002 Mar; 102(3):275-82. PubMed ID: 11890714
[TBL] [Abstract][Full Text] [Related]
35. Structural and functional impact of the transgenic expression of cytokines in the CNS.
Campbell IL
Ann N Y Acad Sci; 1998 May; 840():83-96. PubMed ID: 9629240
[TBL] [Abstract][Full Text] [Related]
36. Chronic neuron-specific tumor necrosis factor-alpha expression enhances the local inflammatory environment ultimately leading to neuronal death in 3xTg-AD mice.
Janelsins MC; Mastrangelo MA; Park KM; Sudol KL; Narrow WC; Oddo S; LaFerla FM; Callahan LM; Federoff HJ; Bowers WJ
Am J Pathol; 2008 Dec; 173(6):1768-82. PubMed ID: 18974297
[TBL] [Abstract][Full Text] [Related]
37. Immune invasion of the central nervous system parenchyma and experimental allergic encephalomyelitis, but not leukocyte extravasation from blood, are prevented in macrophage-depleted mice.
Tran EH; Hoekstra K; van Rooijen N; Dijkstra CD; Owens T
J Immunol; 1998 Oct; 161(7):3767-75. PubMed ID: 9759903
[TBL] [Abstract][Full Text] [Related]
38. Neurobehavioral alterations in developing transgenic mice expressing TNF-alpha in the brain.
Fiore M; Probert L; Kollias G; Akassoglou K; Alleva E; Aloe L
Brain Behav Immun; 1996 Jun; 10(2):126-38. PubMed ID: 8811936
[TBL] [Abstract][Full Text] [Related]
39. Distribution and characterization of tumor necrosis factor-alpha-like immunoreactivity in the murine central nervous system.
Breder CD; Tsujimoto M; Terano Y; Scott DW; Saper CB
J Comp Neurol; 1993 Nov; 337(4):543-67. PubMed ID: 8288770
[TBL] [Abstract][Full Text] [Related]
40. Anti-tumor necrosis factor therapy abrogates autoimmune demyelination.
Selmaj K; Raine CS; Cross AH
Ann Neurol; 1991 Nov; 30(5):694-700. PubMed ID: 1722388
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
